Cytochrome c Antibody, anti-human/mouse/rat, REAfinity™
Synonyms: Cyt c
RECOMBINANT EXTENDED VALIDATION
Bioz Star93/100 Bioz rating
10 Citations
Clone:
REA702 | 6H2.B4
Type of antibody:
Primary antibodies, Recombinant antibodies
Isotype:
recombinant human IgG1
Applications:
ICFC Glossary
External link icon
Quality Assurance Certified ProductSatisfaction
guaranteed
more »
Select a conjugate:
Select a size:
Other sizes

Related products for Cytochrome c Antibody, anti-human/mouse/rat, REAfinity™

Intracellular flow cytometry applications
APC
FITC
PE
PE-Vio 615
PE-Vio 770
Vio B515
Recommended dilution:
1:50
Remark:
The antibody is suited for staining of formaldehyde-fixed cells.
Data source:
Miltenyi Biotec
Conjugate:
APC
Used products:
130-111-368, 130-111-180
Description:
Human lymphocytes were fixed and permeabilized followed by intracellular staining with Anti-Cytochrome c antibodies or with the corresponding REA Control (I) antibodies (left peak). Flow cytometry was performed using the MACSQuant® Analyzer. Cell debris was excluded from the analysis based on scatter signals.

Application image
Intracellular flow cytometry applications
PE-Vio 615
PE-Vio 770
Vio B515
Description:
Human lymphocytes were fixed and permeabilized followed by intracellular staining with Anti-Cytochrome c antibodies or with the corresponding REA Control (I) antibodies (left peak). Flow cytometry was performed using the MACSQuant® Analyzer. Cell debris was excluded from the analysis based on scatter signals.
Extended validation for Cytochrome c Antibody, anti-human/mouse/rat, REAfinity™
Specificity
Epitope competition assay

In order to compare the epitope specificity of an antibody, the clone being used is compared with other known clones recognizing the same antigen in a competition assay.

Other clones
Overlap in epitope recognition with REA702
6H2
high
6H2.B4
high
7H8.2C12
partial

Cells were incubated with an excess of purified unconjugated Cytochrome c (REA702) antibody followed by staining with fluorochrome-conjugated antibodies from other known clones targeting the same antigen. Fluorescence intensity was then used to assess epitope overlap: a minimal or absent signal indicated high epitope overlap, an intermediate signal suggested partial overlap, and a strong signal reflected low overlap.

Specifications for Cytochrome c Antibody, anti-human/mouse/rat, REAfinity™
Overview

Clone REA702 recognizes the human, mouse, and rat cytochrome c, a 15 kDa hemeprotein located in the intermembrane of the mitochondrion. Cytochromes are involved in cell respiration, photosynthesis, and other biochemical reactions. Cytochrome c plays also a role in apoptosis, by release to cytoplasma and binding Apaf-1 which activates procaspase 9. Cytochrome c is found in plants, animals, and many unicellular organisms and catalyzes the electron transfer from reduced cytochrome c to oxygen.

Additional information: Clone REA702 displays negligible binding to Fc receptors.

Alternative names

Cyt c

Detailed product information

Technical specifications

Clone
REA702
Clonality
monoclonal
Isotype
recombinant human IgG1
Isotype control
REA Control Antibody (I), human IgG1
Host
human cell line
Type of antibody
Primary antibodies, Recombinant antibodies
Species reactivity
human, mouse, rat
Antigen
Cytochrome c
Molecular mass of antigen [kDa]
12, same molecular weight for human and mouse/rat
Distribution of antigen
ubiquitous
Entrez Gene ID
RRID
AB_2922357, AB_2922366, AB_2651486, AB_2651487, AB_2651488, AB_2651489, AB_2651485, AB_2651484

Recombinant antibodies at Miltenyi Biotec

As an innovation-powered company with a commitment to quality and excellence, Miltenyi Biotec applies cutting-edge methods to discover and develop newer and better antibodies to satisfy both market demand and regulatory requirements.

The Miltenyi way of generating best-in-class antibodies and antibody conjugates

At Miltenyi Biotec, we opt for recombinant antibodies, which enable sequence verification and optimization for lot-to-lot consistency, making them superior to hybridoma-based antibodies.

Infusing our unique expertise

Recombinants are the result of combining genetic material from different immunized animals, and using display technologies to screen in-house antibody libraries for the best antibodies. Additional analyses on existing hybridoma-based antibodies can also give rise to sequences contributing to novel recombinants.

Maximizing value for your research

By further re-engineering these antibody sequences, we can precisely control their properties to achieve the following benefits:

reduce undesirable binding to Fc gamma receptors,

  • eliminate destabilizing amino acid motifs,
  • increase specific bonding affinity for stronger, more accurate targeting, and
  • optimize fluorochrome conjugation for brighter and clearer signals.

In a final step, by synthesizing and cloning the resulting gene sequence, we achieve an expression vector that develops a cell line, which in turn produces a special recombinant antibody.

Better science with quality antibodies

Already in 2015, 100 of the world’s leading scientists collectively called for better standards and reproducibility in antibody production, proposing recombinant antibodies to circumvent variability (Baker, M. Reproducibility crisis: Blame it on the antibodies. Nature 521, 274–276 (2015). https://doi.org/10.1038/521274a). Moreover, by applying reverse engineering, which is encouraged by the EU Directive 2016/943 r, Miltenyi Biotec acts “[i]n the interest of innovation and fostering competition…” (§16).

Resources for Cytochrome c Antibody, anti-human/mouse/rat, REAfinity™
Certificates

To access a Certificate of Analysis (CoA) follow the link below and enter the specific lot of your product.

Get certificate

Should you wish to request additional documentation, such as a Safety Data Sheet (SDS) in other languages than English or Swedish, an SDS-replacement document, or a Certificate of Origin (CoO), please direct your inquiry to your local technical support team.

Contact technical support

You have previously chosen International as your location.
What do you want to do?